| 吗多明; 吗斯酮胺 |
Molsidomine |
|
| 吗多明杂质B |
Molsidomine impurity B |
|
| 吗多明杂质D |
Molsidomine impurity D |
|
| 糠酸莫米他松 |
Mometasone furoate |
83919-23-7 |
| 酒石酸氢莫仑太尔 |
Morantel hydrogen tartrate |
| 盐酸吗啡 |
Morphine hydrochloride (trihydrate) - * narc |
| 硫酸吗啡 |
Morphine sulphate - * narc |
| 吗啡系统适应 |
Morphine for system suitability - * narc |
| 莫昔克丁 |
Moxidectin |
113507-06-5 |
| 莫昔克丁系统适应 |
Moxidectin for system suitability |
| 盐酸莫西沙星 |
Moxifloxacin hydrochloride |
186826-86-8 |
| 莫西沙星峰鉴别 |
Moxifloxacin for peak identification |
| 莫索尼定 |
Moxonidine |
|
| 莫索尼定杂质A |
Moxonidine impurity A |
|
| 腮腺炎疫苗(有活性) |
Mumps vaccine (live) BRP |
| 莫匹罗星-图谱 |
Mupirocin - reference spectrum |
| 莫匹罗星钙-图谱 |
Mupirocin calcium - reference spectrum |
| 莫匹罗星锂 |
Mupirocin lithium |
73346-79-9 |
| 麦考酚酸酯 霉酚酸酯 |
Mycophenolate mofetil |
128794-94-5 |
| 麦考酚酸酯峰鉴别 |
Mycophenolate mofetil for peak identification |
| 发酵支原体 |
Mycoplasma fermentans BRP |
| 猪鼻支原体 |
Mycoplasma hyorhinis BRP |
| 口腔支原体 |
Mycoplasma orale BRP |
|
| 滑液囊支原体 |
Mycoplasma synoviae BRP |
| 肌醇 |
Myo-inositol |
87-89-8 |
| 萘丁美酮 |
Nabumetone |
42924-53-8 |
| 萘丁美酮杂质D |
Nabumetone impurity D |
|
| 萘丁美酮杂质F |
Nabumetone impurity F |
29619-45-2 |
| 纳多洛尔 |
Nadolol |
42200-33-9 |
| 那屈肝素钙 |
Nadroparin calcium |
37270-89-6 |
| 萘呋胺-图谱 |
Naftidrofuryl - reference spectrum |
| 萘呋胺杂质A |
Naftidrofuryl impurity A |
| 萘呋胺杂质B |
Naftidrofuryl impurity B |
| 萘呋胺杂质C |
Naftidrofuryl impurity C |
| 萘呋胺杂质F |
Naftidrofuryl impurity F |
| 奈啶酸 萘啶酮酸 |
Nalidixic acid |
|
| 纳洛酮,烯丙羟吗啡酮(吗啡拮抗剂) |
Naloxone hydrochloride dihydrate |
| 纳洛酮峰鉴别 |
Naloxone for peak identification |
| 纳曲酮; 环丙羟二氢吗啡酮 |
Naltrexone hydrochloride |